T. Rowe Price Associates
DVAX

T. Rowe Price Associates’s Dynavax Technologies DVAX Stock Holding History

T. Rowe Price Associates’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-102,996
Closed -$1.58M – 3154
2025
Q4 		$1.58M Buy
102,996
+4,909
+5% +$54.1K ﹤0.01% 1862
2025
Q3 		$975K Buy
98,087
+7,260
+8% +$75.6K ﹤0.01% 2085
2025
Q2 		$902K Sell
90,827
-5,736
-6% -$60.4K ﹤0.01% 2026
2025
Q1 		$1.25M Buy
96,563
+9,081
+10% +$120K ﹤0.01% 1839
2024
Q4 		$1.12M Buy
87,482
+8,699
+11% +$105K ﹤0.01% 1920
2024
Q3 		$878K Sell
78,783
-21,615
-22% -$238K ﹤0.01% 2024
2024
Q2 		$1.13M Buy
100,398
+4,861
+5% +$56.6K ﹤0.01% 1850
2024
Q1 		$1.19M Buy
95,537
+9,839
+11% +$128K ﹤0.01% 1834
2023
Q4 		$1.2M Buy
85,698
+8,153
+11% +$113K ﹤0.01% 1769
2023
Q3 		$1.15M Buy
77,545
+3,333
+4% +$46.9K ﹤0.01% 1729
2023
Q2 		$959K Buy
74,212
+5,266
+8% +$60K ﹤0.01% 1833
2023
Q1 		$677K Buy
68,946
+2,202
+3% +$23.5K ﹤0.01% 1976
2022
Q4 		$710K Sell
66,744
-6,494
-9% -$75.5K ﹤0.01% 1964
2022
Q3 		$765K Buy
73,238
+7,876
+12% +$103K ﹤0.01% 1898
2022
Q2 		$823K Buy
65,362
+13,264
+25% +$141K ﹤0.01% 1981
2022
Q1 		$565K Sell
52,098
-20,231
-28% -$246K ﹤0.01% 2279
2021
Q4 		$1.02M Buy
72,329
+29,014
+67% +$477K ﹤0.01% 2034
2021
Q3 		$832K Sell
43,315
-13,073
-23% -$174K ﹤0.01% 2137
2021
Q2 		$555K Sell
56,388
-18,151
-24% -$165K ﹤0.01% 2342
2021
Q1 		$733K Sell
74,539
-24,466
-25% -$202K ﹤0.01% 2191
2020
Q4 		$441K Buy
99,005
+200
+0.2% +$905 ﹤0.01% 2296
2020
Q3 		$427K Sell
98,805
-9,416
-9% -$67.2K ﹤0.01% 2153
2020
Q2 		$960K Sell
108,221
-56,132
-34% -$284K ﹤0.01% 1800
2020
Q1 		$580K Buy
164,353
+426
+0.3% +$1.98K ﹤0.01% 1912
2019
Q4 		$938K Sell
163,927
-16,556
-9% -$88.5K ﹤0.01% 1909
2019
Q3 		$645K Buy
180,483
+137,567
+321% +$533K ﹤0.01% 2001
2019
Q2 		$171K Buy
42,916
+100
+0.2% +$580 ﹤0.01% 2428
2019
Q1 		$313K Buy
42,816
+200
+0.5% +$1.96K ﹤0.01% 2277
2018
Q4 		$390K Sell
42,616
-23,287
-35% -$258K ﹤0.01% 2178
2018
Q3 		$817K Sell
65,903
-731
-1% -$9.89K ﹤0.01% 1945
2018
Q2 		$1.02M Buy
66,634
+26,875
+68% +$465K ﹤0.01% 1831
2018
Q1 		$789K Buy
39,759
+7,319
+23% +$126K ﹤0.01% 1886
2017
Q4 		$607K Sell
32,440
-28
-0.1% -$562 ﹤0.01% 2009
2017
Q3 		$698K Sell
32,468
-3,638
-10% -$57.6K ﹤0.01% 1945
2017
Q2 		$348K Sell
36,106
-274
-0.8% -$1.78K ﹤0.01% 2186
2017
Q1 		$216K Hold
36,380
– – ﹤0.01% 2370
2016
Q4 		$144K Hold
36,380
– – ﹤0.01% 2432
2016
Q3 		$382K Buy
36,380
+10,600
+41% +$152K ﹤0.01% 2115
2016
Q2 		$376K Buy
25,780
+4,800
+23% +$82K ﹤0.01% 2075
2016
Q1 		$404K Hold
20,980
– – ﹤0.01% 2062
2015
Q4 		$507K Buy
20,980
+600
+3% +$15K ﹤0.01% 1953
2015
Q3 		$500K Hold
20,380
– – ﹤0.01% 1944
2015
Q2 		$477K Hold
20,380
– – ﹤0.01% 2020
2015
Q1 		$457K Sell
20,380
-200
-1% -$3.83K ﹤0.01% 2016
2014
Q4 		$347K Hold
20,580
– – ﹤0.01% 2117
2014
Q3 		$294K Hold
20,580
– – ﹤0.01% 2157
2014
Q2 		$329K Hold
20,580
– – ﹤0.01% 2138
2014
Q1 		$370K Hold
20,580
– – ﹤0.01% 2049
2013
Q4 		$403K Buy
20,580
+10,300
+100% +$151K ﹤0.01% 2005
2013
Q3 		$123K Buy
10,280
+4,930
+92% +$62K ﹤0.01% 2363
2013
Q2 		$59K Buy
+5,350
New +$113K ﹤0.01% 2390

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

T. Rowe Price Associates's DVAX Position: Q1 2026 in Review

T. Rowe Price Associates sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 102,996 shares — an estimated $1.58M sold.

T. Rowe Price Associates first reported a position in DVAX in Q2 2013 and held it in 51 quarters. The position peaked at $1.58M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • T. Rowe Price Associates reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Associates sold 102,996 Dynavax Technologies shares in Q1 2026, an estimated $1.58M.
  • T. Rowe Price Associates first reported a position in Dynavax Technologies in Q2 2013 and held it in 51 quarters.
  • T. Rowe Price Associates's Dynavax Technologies position peaked at $1.58M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.